EFTA01118265
EFTA01118268 DataSet-9
EFTA01118275

EFTA01118268.pdf

DataSet-9 7 pages 1,350 words document
P17 P21 V11 P19 D1
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (1,350 words)
Neoteny 3, LP - Fund Partnership Neoteny 3 Management, LLC - General Partner nicor‘tivq3 Quarterly Report June 30, 2015 c/o Neoteny 3 Management, LLC do Prague & Company, P.C. Fifteen Walnut Street, Suite I50 Phone: E-mail 2: www.neoteny.com EFTA01118268 leIVffoi6cnici3 June 30, 2015 Quarterly Report CONTENTS LETTER FROM THE GENERAL PARTNER 3 NEOTENY 3, LP INVESTMENT PORTFOLIO 4 Cash and Cash Equivalents Balance 4 Portfolio Companies 4 NEOTENY 3, LP UNAUDITED FINANCIAL STATEMENTS 5 Balance Sheet 5 Profit and Loss Statement 6 APPENDIX I - PORTFOLIO COMPANY DESCRIPTIONS 7 Neoteny 3, LP I CONFIDENTIAL - NOT FOR DISTRIBUTION 2 EFTA01118269 Ncor‘ovq_y June 30. 2015 Quarterly Report LETTER FROM THE GENERAL PARTNER August 13, 2015 Dear Partners, June 30, 2015 marked the first quarter end for Neoteny 3, LP (the "Fund"). After the initial close on March 31, 2015, the Fund made a capital call on April 2, 2015 equal to 100% of partners' capital commitments (subject to certain foreign regulatory limitations). During the quarter, the Fund continued to receive interest from potential investors, and a number of these investors have now been accepted as partners. As of June 30, 2015, the Fund has received total capital commitments of $7,800,000, of which $6,250,000 has been called and paid-in. The remaining capital will be called prior to the quarter ended September 30, 2015 as the Fund has now received the required foreign regulatory approvals. The Fund will continue to welcome inquiries from potential investors through the earlier of its first distribution to partners or December 31, 2015 (final closing date), but intends to cap the Fund at $10,000,000. Upon the initial close, the Fund began acquiring investments in portfolio companies. As of June 30, 2015, the Fund has invested $1,008,066 in seven portfolio companies. Please see the next section for a summary of the Fund's investment portfolio as of June 30, 2015. The Fund will continue to seek out additional investment opportunities in the coming months and work strategically with others to build out its investment portfolio. To this end, the Fund recognizes that many of its partners are professional investors, business executives, innovators, industry leaders and the like. The Fund encourages these individuals to share any potential investment opportunities they may have with the Fund. In turn, to the extent possible, the Fund will do the same for its partners. One of the reasons many people have invested in the Fund is to be exposed to the portfolio companies. Many of the portfolio companies are interested in the Fund's partners as well. In this way, it is quite different from a traditional find. The Fund would like to make a list of partners available to the portfolio companies when talking to them. Please let the Fund know if you are interested or willing to be disclosed in this way, and if so, how you would like to be listed, as many of you are using investment vehicles. In addition, a number of partners have expressed interest in meeting each other and potentially some of the portfolio companies. The Fund is considering the feasibility of a meeting, so please also indicate whether you would be interested in such a gathering. Please e-mail Danielle Prague with your preferences ([email protected]). As you know, the Fund maintains an online secure sharing platform through Intralinks (www.intralinks.com). You may use this platform to view Schedule K-Is, annual and quarterly reports, and information about the Fund's portfolio companies. Of note, the "Investment information and News" folder contains an "Investment Tracker" that reflects the Fund's investments to date. If you have any questions or comments, please feel free to contact the Fund. Thank you for your support. Sincerely, 72. .0C ) Joichi Ito, as manager of Neoteny 3 Management, LLC, the General Partner ofNeoteny 3, LP Neoteny 3, LP I CONFIDENTIAL - NOT FOR DISTRIBUTION 3 EFTA01118270 nitO1O1)1(f_Y June 30, 2015 Quarterly Report NEOTENY 3, LP INVESTMENT PORTFOLIO Cash and Cash Equivalents Balance (All amounts in United States Dollarsail Cash and Cash Equivalents Amount (S) Beginning of the Quarter - April I, 2015 (Inception) so Funds Raised $6,250,000 Capital Invested S(I 008 066) Expenses / Organizational Costs 5(116,123) Other Items $30 End of the Quarter -June 30, 2015 $5,123,841 Portfolio Companies (All amounts in United States Dollars(S)) Company Name Investment Date Amount (S)r Investment Type Website Crowd Supply. Inc. Apr. 22. 2015 $101341 492,805 shares of Series Seed II Prefaced Stock www.crowdsupply.00m Emerald Therapeutics. Inc. I Jun. 19, 2015 S100,064 25.916 shares of Series C Preferred Stock www.emenldeloudlab.com Kemoko, Inc. (a/k/a Panoply) Feb. 20, 2015 S100.000 128,568 shares of Series Seed Preferred Stock www.itskoko.com O112 Laboratories, 1.1.0 Apr. 7, 2015 S175,533 Convenible promissory note www.oh2labonitories.com 575,532 50.000 Funding Units Top Flight Technologies, Inc. Jun. 8.2015 $250,035 Convertible promissory notc www.thightiech.com Udu. Inc. Mar. 31,201$ $10/,059 Convertible promissory note twitteccomtuduinc SO Warrant for 20,000 shares of Common Stock Wearality Comonnion Apr. 27, 2015 $101,502 Convertible promissory note www.wearality.com TOTAL $1,008,066 Amount means the original purchase price ofeach investment plus associated capital expenditures. Neoteny 3, LP I CONFIDENTIAL - NOT FOR DISTRIBUTION 4 EFTA01118271 Ncotffivq3 June 30, 2015 Quarterly Report NEOTENY 3, LP UNAUDITED FINANCIAL STATEMENTS Balance Sheet Unaudited, U.S. Tax Basis As of June 30, 2015 (All amounts in United States Dollars(S)) YEAR TO DATE JUNE 30,2015 ASSETS CURRENT ASSETS Cash and Cash Equivalents $5,125,841 TOTAL CURRENT ASSETS $5,125,841 OTHER ASSETS Investments in Portfolio Companies $1,008,066 Organizational Costs $86,692 I Accumulated Amortization $(1,445) ;Net Organizational Costs $85,247 TOTAL OTHER ASSETS S1,093,313 TOTAL ASSETS $6,219,154 LIABILITIES AND EQUITY CURRENT LIABILITIES Due To Partners $30 TOTAL CURRENT LIABILITIES $30 TOTAL LIABILITIES $30 EQUITY Partners' Capital Accounts $6,250,000 Net Income/(Loss) $(30,876) TOTAL EQUITY $6,219,124 TOTAL LIABILITIES AND EQUITY $6,219,154 Neoteny 3, LP I CONFIDENTIAL - NOT FOR DISTRIBUTION EFTA01118272 NE0'6041(13 June 30, 2015 Quarterly Report Profit and Loss Statement Unaudited, U.S. Tax Basis Through Quarter Ended June 30, 2015 (All amounts In United States Dollars (3)) YEAR TO DATE TUNE 30, 2015 EXPENSES Fund Expenses $29,431 Amortization Expense - Organizational Costs $1,445 TOTAL EXPENSES $30,876 NET INCOME / (LOSS) S(30,876) Neoteny 3, LP I CONFIDENTIAL - NOT FOR DISTRIBUTION 6 EFTA01118273 enica6tivq3 June 30, 2015 Quarterly Report APPENDIX I - PORTFOLIO COMPANY DESCRIPTIONS • Crowd Supply, Inc. is a crowdfunding platform focused on new product development projects. The platform supports campaigns, pre-orders (once a campaign has been successfully funded) and e-commerce sales of completed, fully manufactured products. • Emerald Therapeutics, Inc. is a venture-backed biotechnology company based in San Francisco, California. One of the projects it has launched is the Emerald Cloud Lab, a web-based life sciences lab, developed by scientists for scientists. ECL conducts lab experiments designed by customers, collects the data and organizes it into a database its customers can access remotely. • Kemoko, Inc. (a/k/a Panoply) is the company behind the mobile app Koko. Koko was designed to provide peer-to-peer mental health support through a social network that actually helps you feel better. Koko has yet to be launched for public use. • OH2 Laboratories, LLC is a synthetic materials lab. The company mainly focuses on developing variant water-soluble O-protein-coupled receptors (GPCRs) that maintain the functionality of the original. It also provides consulting services to pharma and other research entities. It continues to seek ways to monetize its technologies in drug and related arenas. • Top Flight Technologies, Inc. is dedicated to application-specific, cost effective commercial solutions of unmanned aircraft vehicles (UAVs) using the latest advanced technologies driving automation and safety. A key innovation is a very small gasoline-based hybrid engine that has very high energy densities compared to batteries. • Udu, Inc. is a scheduling and communication platform built on a web services abstraction framework; chat, exchange media, and share with your favorite social networks, while the udu app does the work of planning the event. • Wearality Corporation develops field of view (FOV) head wearable display technology that is comfortable and gives a natural visual experience. It is the creative force behind Wearality Sky, lightweight, fold-able, opensource 3D glasses that put a movie theater in your pocket. Neoteny 3, LP I CONFIDENTIAL - NOT FOR DISTRIBUTION 7 EFTA01118274
ℹ️ Document Details
SHA-256
25a58d9c1c14bc7cb9aee41b70e7fceb2cde775b1a75d2db22004100e529856f
Bates Number
EFTA01118268
Dataset
DataSet-9
Document Type
document
Pages
7

Comments 0

Loading comments…
Link copied!